Alberto Mazza
About
In The Last Decade
Alberto Mazza
23 papers receiving 340 citations
Peers
Comparison fields: 5 of 76
- Cardiology and Cardiovascular Medicine 277
- Endocrinology, Diabetes and Metabolism 65
- Nutrition and Dietetics 35
- Pulmonary and Respiratory Medicine 27
- Surgery 25
Countries citing papers authored by Alberto Mazza
This map shows the geographic impact of Alberto Mazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Mazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Mazza more than expected).
Fields of papers citing papers by Alberto Mazza
This network shows the impact of papers produced by Alberto Mazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Mazza. The network helps show where Alberto Mazza may publish in the future.
Co-authorship network of co-authors of Alberto Mazza
This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Mazza. A scholar is included among the top collaborators of Alberto Mazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Mazza. Alberto Mazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 20 | |
| 5 | 10 | |
| 6 | 9 | |
| 7 | (99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up study. | 1 |
| 8 | 9 | |
| 9 | 10 | |
| 10 | Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects. | 1 |
| 11 | 23 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 31 | |
| 15 | [Bolus injection of recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in massive pulmonary embolism complicated with heart arrest. Report of 2 cases and review of the literature]. | 1 |
| 16 | 45 | |
| 17 | 5 | |
| 18 | 17 | |
| 19 | 6 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.